{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:37:09Z","timestamp":1794562629997,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":38,"publisher":"Springer New York","isbn-type":[{"value":"9781493977031","type":"print"},{"value":"9781493977048","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-7704-8_8","type":"book-chapter","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T10:22:26Z","timestamp":1520331746000},"page":"125-137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mass Spectrometry-Based Metabolomic Multiplatform for Alzheimer\u2019s Disease Research"],"prefix":"10.1007","author":[{"given":"Ra\u00fal","family":"Gonz\u00e1lez-Dom\u00ednguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Gonz\u00e1lez-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Sayago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngeles","family":"Fern\u00e1ndez-Recamales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"8_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrneurol.2011.2","volume":"7","author":"C Reitz","year":"2011","unstructured":"Reitz C, Brayne C, Mayeux R (2011) Epidemiology of Alzheimer disease. Nat Rev Neurol 7:137\u2013152","journal-title":"Nat Rev Neurol"},{"key":"8_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"K Blennow","year":"2006","unstructured":"Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer\u2019s disease. Lancet 368:387\u2013403","journal-title":"Lancet"},{"key":"8_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0188-4409(01)00316-2","volume":"32","author":"RB Maccioni","year":"2001","unstructured":"Maccioni RB, Mu\u00f1oz JP, Barbeito L (2001) The molecular bases of Alzheimer\u2019s disease and other neurodegenerative disorders. Arch Med Res 32:367\u2013381","journal-title":"Arch Med Res"},{"key":"8_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1039\/C3MT00301A","volume":"9","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2014","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, G\u00f3mez-Ariza JL (2014) Characterization of metal profiles in serum during the progression of Alzheimer\u2019s disease. Metallomics 9:292\u2013300","journal-title":"Metallomics"},{"key":"8_CR5","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"B Dubois","year":"2007","unstructured":"Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O\u2019Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS\u2013ADRDA criteria. Lancet Neurol 6:734\u2013746","journal-title":"Lancet Neurol"},{"key":"8_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jchromb.2017.02.008","volume":"1071","author":"Ra\u00fal Gonz\u00e1lez-Dom\u00ednguez","year":"2017","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Sayago A, Fern\u00e1ndez-Recamales A (2017) Metabolomics in Alzheimer\u2019s disease: the need of complementary analytical platforms for the identification of biomarkers to unravel the underlying pathology. J Chromatogr B Analyt Technol Biomed Life Sci 1071:75\u201392","journal-title":"Journal of Chromatography B"},{"key":"8_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1039\/B906712B","volume":"40","author":"WB Dunn","year":"2011","unstructured":"Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL (2011) Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev 40:387\u2013426","journal-title":"Chem Soc Rev"},{"key":"8_CR8","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1007\/s11306-013-0524-y","volume":"9","author":"AHM Emwas","year":"2013","unstructured":"Emwas AHM, Salek RM, Griffin JL, Merzaban J (2013) NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations. Metabolomics 9:1048\u20131072","journal-title":"Metabolomics"},{"key":"8_CR9","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/mas.20306","volume":"30","author":"G Theodoridis","year":"2011","unstructured":"Theodoridis G, Gika HG, Wilson ID (2011) Mass spectrometry-based holistic analytical approaches for metabolite profiling in systems biology studies. Mass Spectrom Rev 30:884\u2013906","journal-title":"Mass Spectrom Rev"},{"key":"8_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4155\/bio-2016-0202","volume":"9","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2017","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Sayago A, Fern\u00e1ndez-Recamales A (2017) Direct infusion mass spectrometry for metabolomic phenotyping of diseases. Bioanalysis 9:131\u2013148","journal-title":"Bioanalysis"},{"key":"8_CR11","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1021\/cr300484s","volume":"113","author":"NL Kuehnbaum","year":"2013","unstructured":"Kuehnbaum NL, Britz-McKibbin P (2013) New advances in separation science for metabolomics: resolving chemical diversity in a post-genomic era. Chem Rev 113:2437\u20132468","journal-title":"Chem Rev"},{"key":"8_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jchromb.2008.04.033","volume":"871","author":"KK Pasikanti","year":"2008","unstructured":"Pasikanti KK, Ho PC, Chan EC (2008) Gas chromatography\/mass spectrometry in metabolic profiling of biological fluids. J Chromatogr B Analyt Technol Biomed Life Sci 871:202\u2013211","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"8_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/hmg\/ddh019","volume":"13","author":"JL Jankowsky","year":"2004","unstructured":"Jankowsky JL, Fadale DJ, Anderson J, GM X, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, Younkin SG, Borchelt DR (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific g secretase. Hum Mol Genet 13:159\u2013170","journal-title":"Hum Mol Genet"},{"key":"8_CR14","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.1007\/s00216-014-8102-3","volume":"406","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2014","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, G\u00f3mez-Ariza JL (2014) Using direct infusion mass spectrometry for serum metabolomics in Alzheimer\u2019s disease. Anal Bioanal Chem 406:7137\u20137148","journal-title":"Anal Bioanal Chem"},{"key":"8_CR15","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/j.bbadis.2014.09.014","volume":"1842","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2014","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, Vitorica J, G\u00f3mez-Ariza JL (2014) Region-specific metabolic alterations in the brain of the APP\/PS1 transgenic mice of Alzheimer\u2019s disease. Biochim Biophys Acta 1842:2395\u20132402","journal-title":"Biochim Biophys Acta"},{"key":"8_CR16","doi-asserted-by":"publisher","first-page":"13315","DOI":"10.1007\/s11356-014-2741-y","volume":"21","author":"A Gago-Tinoco","year":"2014","unstructured":"Gago-Tinoco A, Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, Blasco-Moreno J, Bebianno MJ, G\u00f3mez-Ariza JL (2014) Metabolic signatures associated with environmental pollution by metals in Do\u00f1ana National Park using P. clarkii as bioindicator. Environ Sci Pollut Res Int 21:13315\u201313323","journal-title":"Environ Sci Pollut Res Int"},{"key":"8_CR17","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1002\/elps.201400544","volume":"36","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, Vitorica J, G\u00f3mez-Ariza JL (2015) High throughput multi-organ metabolomics in the APP\/PS1 mouse model of Alzheimer\u2019s disease. Electrophoresis 36:2237\u20132249","journal-title":"Electrophoresis"},{"key":"8_CR18","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1039\/b604498k","volume":"131","author":"T Sangster","year":"2006","unstructured":"Sangster T, Major H, Plumb R, Wilson AJ, Wilson ID (2006) A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. Analyst 131:1075\u20131078","journal-title":"Analyst"},{"key":"8_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jpba.2014.10.010","volume":"107","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, G\u00f3mez-Ariza JL (2015) Metabolite profiling for the identification of altered metabolic pathways in Alzheimer\u2019s disease. J Pharm Biomed Anal 107:75\u201381","journal-title":"J Pharm Biomed Anal"},{"key":"8_CR20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jpba.2014.10.009","volume":"102","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, Vitorica J, G\u00f3mez-Ariza JL (2015) Metabolomic screening of regional brain alterations in the APP\/PS1 transgenic model of Alzheimer\u2019s disease by direct infusion mass spectrometry. J Pharm Biomed Anal 102:425\u2013435","journal-title":"J Pharm Biomed Anal"},{"key":"8_CR21","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.talanta.2014.07.075","volume":"131","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, G\u00f3mez-Ariza JL (2015) Application of a novel metabolomic approach based on atmospheric pressure photoionization mass spectrometry using flow injection analysis for the study of Alzheimer\u2019s disease. Talanta 131:480\u2013489","journal-title":"Talanta"},{"key":"8_CR22","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jpba.2015.01.025","volume":"107","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, Vitorica J, G\u00f3mez-Ariza JL (2015) Application of metabolomics based on direct mass spectrometry analysis for the elucidation of altered metabolic pathways in serum from the APP\/PS1 transgenic model of Alzheimer\u2019s disease. J Pharm Biomed Anal 107:378\u2013385","journal-title":"J Pharm Biomed Anal"},{"key":"8_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.biochi.2015.01.005","volume":"110","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, Vitorica J, G\u00f3mez-Ariza JL (2015) Deciphering metabolic abnormalities associated with Alzheimer\u2019s disease in the APP\/PS1 mouse model using integrated metabolomic approaches. Biochimie 110:119\u2013128","journal-title":"Biochimie"},{"key":"8_CR24","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1039\/C4MB00747F","volume":"11","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, Vitorica J, G\u00f3mez-Ariza JL (2015) Metabolomic investigation of systemic manifestations associated with Alzheimer\u2019s disease in the APP\/PS1 transgenic mouse model. Mol BioSyst 11:2429\u20132440","journal-title":"Mol BioSyst"},{"key":"8_CR25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/elps.201400450","volume":"36","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, Vitorica J, G\u00f3mez-Ariza JL (2015) Metabolomics reveals significant impairments in the immune system of the APP\/PS1 transgenic mice of Alzheimer\u2019s disease. Electrophoresis 36:577\u2013587","journal-title":"Electrophoresis"},{"key":"8_CR26","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1021\/ac051437y","volume":"78","author":"CA Smith","year":"2006","unstructured":"Smith CA, Want EJ, O\u2019Maille G, Abagyan R, Siuzdak G (2006) XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 78:779\u2013787","journal-title":"Anal Chem"},{"key":"8_CR27","doi-asserted-by":"publisher","first-page":"5864","DOI":"10.1021\/ac201065j","volume":"83","author":"KA Veselkov","year":"2011","unstructured":"Veselkov KA, Vingara LK, Masson P, Robinette SL, Want E, Li JV, Barton RH, Boursier-Neyret C, Walther B, Ebbels TM, Pelczer I, Holmes E, Lindon JC, Nicholson JK (2011) Optimized preprocessing of ultra-performance liquid chromatography\/mass spectrometry urinary metabolic profiles for improved information recovery. Anal Chem 83:5864\u20135872","journal-title":"Anal Chem"},{"key":"8_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1471-2164-7-142","volume":"7","author":"RA Berg van den","year":"2006","unstructured":"van den Berg RA, Hoefsloot HCJ, Westerhuis JA, Smilde AK, van der Werf MJ (2006) Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 7:142","journal-title":"BMC Genomics"},{"key":"8_CR29","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/rcm.6155","volume":"26","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2012","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, G\u00f3mez-Ariza JL (2012) Iberian ham typification by direct infusion electrospray and photospray ionization mass spectrometry fingerprinting. Rapid Commun Mass Spectrom 26:835\u2013844","journal-title":"Rapid Commun Mass Spectrom"},{"key":"8_CR30","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/mas.10061","volume":"22","author":"M Pulfer","year":"2003","unstructured":"Pulfer M, Murphy RC (2003) Electrospray mass spectrometry of phospholipids. Mass Spectrom Rev 22:332\u2013364","journal-title":"Mass Spectrom Rev"},{"key":"8_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.aca.2004.07.065","volume":"525","author":"C Wang","year":"2004","unstructured":"Wang C, Xie S, Yang J, Yang Q, Xu G (2004) Structural identification of human blood phospholipids using liquid chromatography\/quadrupole-linear ion trap mass spectrometry. Anal Chim Acta 525:1\u201310","journal-title":"Anal Chim Acta"},{"key":"8_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jprot.2014.01.014","volume":"104","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2014","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, G\u00f3mez-Ariza JL (2014) Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer\u2019s disease. J Proteome 104:37\u201347","journal-title":"J Proteome"},{"key":"8_CR33","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1016\/j.jchromb.2008.12.057","volume":"877","author":"CA Haynes","year":"2009","unstructured":"Haynes CA, Allegood JC, Park H, Sullards MC (2009) Sphingolipidomics: methods for the comprehensive analysis of sphingolipids. J Chromatogr B 877:2696\u20132708","journal-title":"J Chromatogr B"},{"key":"8_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bbalip.2005.12.007","volume":"1761","author":"G Liebisch","year":"2006","unstructured":"Liebisch G, Binder M, Schifferer R, Langmann T, Schulz B, Schmitz G (2006) High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS\/MS). Biochim Biophys Acta 1761:121\u2013128","journal-title":"Biochim Biophys Acta"},{"key":"8_CR35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0021-9673(02)01838-1","volume":"984","author":"L Vernez","year":"2003","unstructured":"Vernez L, Hopfgartner G, Wenk M, Krahenbuhl S (2003) Determination of carnitine and acylcarnitines in urine by high-performance liquid chromatography-electrospray ionization ion trap tandem mass spectrometry. J Chromatogr A 984:203\u2013213","journal-title":"J Chromatogr A"},{"key":"8_CR36","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1002\/elps.201400196","volume":"35","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2014","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda A, Garc\u00eda-Barrera T, Barbas C, G\u00f3mez-Ariza JL (2014) Metabolomic profiling of serum in the progression of Alzheimer\u2019s disease by capillary electrophoresis-mass spectrometry. Electrophoresis 35:3321\u20133330","journal-title":"Electrophoresis"},{"key":"8_CR37","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2174\/1567205013666160129095138","volume":"13","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2016","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Rup\u00e9rez FJ, Garc\u00eda-Barrera T, Barbas C, G\u00f3mez-Ariza JL (2016) Metabolomic-driven elucidation of pathological mechanisms associated with Alzheimer\u2019s disease and mild cognitive impairment. Curr Alzheimer Res 13:641\u2013653","journal-title":"Curr Alzheimer Res"},{"key":"8_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ab.2014.07.016","volume":"465","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2014","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Castilla-Quintero R, Garc\u00eda-Barrera T, G\u00f3mez-Ariza JL (2014) Development of a metabolomic approach based on urine samples and direct infusion mass spectrometry. Anal Biochem 465:20\u201327","journal-title":"Anal Biochem"}],"container-title":["Methods in Molecular Biology","Biomarkers for Alzheimer\u2019s Disease Drug Development"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7704-8_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T21:35:32Z","timestamp":1603920932000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7704-8_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9781493977031","9781493977048"],"references-count":38,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7704-8_8","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-7704-8","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}